Browsing: Welcome relief

The government’s decision to cap trade margins at 30 per cent of the maximum retail price for all non-scheduled anti-cancer…

An expert panel of the central drugs regulatory authority is likely to take a decision on granting market authorisation to SII’s COVID-19 vaccine Covovax as a heterologous booster dose for adults who have been administered two doses of Covishield or Covaxin